Beck Bode LLC’s Patterson-UTI PTEN Stock Holding History

Beck Bode LLC’s Portfolio PTEN Stock Details PTEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-402,010	Closed	-$6.77M	–	177
2022 Q4	$6.77M	Buy	402,010 +56,193	+16%	+$927K	1.52%	19
2022 Q3	$4.04M	Buy	+345,817	New	+$4.94M	0.88%	34

Other funds holding PTEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Beck Bode LLC's PTEN Position: Q1 2023 in Review

Beck Bode LLC sold out of Patterson-UTI (PTEN) in Q1 2023, closing a stake of 402,010 shares — an estimated $6.77M sold.

Beck Bode LLC first reported a position in PTEN in Q3 2022 and held it in 2 quarters. The position peaked at $6.77M in Q4 2022. 285 funds tracked by Wall St. Rank hold PTEN as of Q1 2023.

Beck Bode LLC reported no remaining Patterson-UTI position as of Q1 2023 after selling out during the quarter.
Beck Bode LLC sold 402,010 Patterson-UTI shares in Q1 2023, an estimated $6.77M.
Beck Bode LLC first reported a position in Patterson-UTI in Q3 2022 and held it in 2 quarters.
Beck Bode LLC's Patterson-UTI position peaked at $6.77M in Q4 2022.
285 funds tracked by Wall St. Rank held Patterson-UTI as of Q1 2023.

Based on Beck Bode LLC's 13F filing for Q1 2023, filed 3 May 2023.